Literature DB >> 1469182

Myasthenia gravis and steroid-induced myopathy of the respiratory muscles.

B Vallet1, F Fourrier, J F Hurtevent, M Parent, C Chopin.   

Abstract

OBJECTIVE: We report a case of corticosteroid-induced myopathy with involvement of respiratory muscles observed in a myasthenic patient. PATIENT: A 37-years-old woman, under corticosteroid treatment for two years for typical myasthenia gravis was admitted to ICU for acute myasthenic respiratory failure. Weaning from mechanical ventilation remained impossible despite 4 plasma exchanges and azathioprine. The patient exhibited a progressive 12 kg weight loss with muscular weakness and atrophy. MEASUREMENTS AND
RESULTS: Peripheral and diaphragmatic electromyography as well as histological study were consistent with a steroid-induced myopathy. Discontinuation of corticosteroid treatment was followed by a rapid weight gain with general improvement and allowed weaning from mechanical ventilation with a complete recovery.
CONCLUSION: This case provides evidence that corticosteroid-induced myopathy may be observed in myasthenia gravis and may involve the respiratory muscles as well as the peripheral musculature.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1469182     DOI: 10.1007/bf01694346

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  Studies in disorders of muscle. XII. Myopathy due to the administration of therapeutic amounts of 17-hydroxycorticosteroids.

Authors:  G T PERKOFF; R SILBER; F H TYLER; G E CARTWRIGHT; M M WINTROBE
Journal:  Am J Med       Date:  1959-06       Impact factor: 4.965

2.  Corticosteroid therapy and respiratory muscle function in humans.

Authors:  Y M Wang; T Zintel; A Vasquez; C G Gallagher
Journal:  Am Rev Respir Dis       Date:  1991-07

3.  Effect of corticosteroids on diaphragm function and biochemistry in the rabbit.

Authors:  G T Ferguson; C G Irvin; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1990-01

Review 4.  Clinical experience in more than 2000 patients with myasthenia gravis.

Authors:  G Genkins; P Kornfeld; A E Papatestas; A N Bender; R J Matta
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  Long-term corticosteroid treatment of myasthenia gravis.

Authors:  T R Johns
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

6.  Steroid myopathy. Clinical, histologic and cytologic observations.

Authors:  A K Afifi; R A Bergman; J C Harvey
Journal:  Johns Hopkins Med J       Date:  1968-10

7.  Acute hydrocortisone myopathy.

Authors:  W Van Marle; K L Woods
Journal:  Br Med J       Date:  1980-07-26

8.  Effect of corticosteroids on respiratory muscle histopathology.

Authors:  G T Ferguson; C G Irvin; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1990-11

9.  Corticosteroid-induced myopathy and the respiratory muscles. Report of two cases.

Authors:  S Janssens; M Decramer
Journal:  Chest       Date:  1989-05       Impact factor: 9.410

10.  Decrease of respiratory muscle strength and static lung volumes in obese asthmatics.

Authors:  E Melzer; J F Souhrada
Journal:  Am Rev Respir Dis       Date:  1980-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.